$RAPH

$1.40 +$0.00 (0.0%) Close

$RAPH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 20.2M shares outstanding

Raphael Pharmaceutical Inc is not yet matched to a CUSIP, so institutional (13F) holdings cannot be attributed to it. The sections below that come from its own filings still apply.

Who owns RAPH?

By type of holder

Institutions 0.0% Insiders 48.9% Everyone else 51.1%

Concentration Top 3 holders own 48.9%

Pilo Shlomo 38.5% · Louria Hayon Igal 6.7%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Raphael Pharmaceutical Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+75.0%

+15.02% a year

Each share's claim on the business

−42.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $2.89M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding RAPH.

Super Investors

Investment managers reporting RAPH on Form 13F

No 13F manager reports holding RAPH yet.

Institutional Funds

Mutual funds and ETFs reporting RAPH on Form N-PORT; together they hold 0.0% of the company

No fund reports holding RAPH yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
PS Pilo Shlomo Insider	7.8M	38.50%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company38.500% Pilo Shlomo's insider activity →
LH Louria Hayon Igal Insider	1.3M	6.69%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company6.690% Louria Hayon Igal's insider activity →

Pilo Shlomo

Insider

7.8M

% of company

38.50%

Change vs last qtr

—

Held since

—

Louria Hayon Igal

Insider

1.3M

% of company

6.69%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of Raphael Pharmaceutical Inc.

Comments